As you might know, one of the main applications of cannabinoids is that they offer palliative care for cancer patients, which reduces pain, inflammation, nausea, and increases appetite.
But with science advancing so quickly, even early clinical trials and cannabinoids to treat cancer in humans have now significantly progressed.
All thanks to the solid legislative efforts and a strong push from marijuana advocates.
For example, The White House press secretary, Jen Psaki, said that approving more cannabis manufacturers for scientific purposes is "a key step in promoting research because it broadens the amount and quality of cannabis available for research purposes."
Even the DEA (Drug Enforcement Administration) announced that it would begin approving applications to allow marijuana growers to become federally authorized to cultivate the plant.
>> How Finding the Right Cannabis Strains Can Help Find the Right Pot Stocks
These are great signs that relevant authorities are seriously considering a fresh look at what was once controversial, which may explain why the government is funding research into marijuana's benefits and risks for cancer patients.
And so far, several studies are proving to be astonishingly positive.
- The Medical College of Georgia at Augusta University revealed that inhaled CND shrinks the size of glioblastoma tumors in an animal experiment, which provided some hope to those suffering from brain tumors.
- Hadassah Medical Center discovered that Cannabotech's (CNTC.TA) medical cannabis products could help kill breast cancer cells up to six times more effective when used in conjunction with standard oncology treatments and drug protocols (e.g. chemotherapy, biological, and hormonal)
- And Cannabotech, which is also developing a botanical drug based on extracts of both cannabinoids and Cyathus striatus fungus, reported that in experiments done on a cell model, the fungus extract eliminated 100% of pancreatic cancer cells without causing harm to normal cells.
Summary
While there's no guarantee that this scientific movement will influence the full legalization of marijuana across the nation and the world, it is steadily proving that doors are opening in this industry. The companies most prepared can not only effectively capture recreational but also the medical market fully. If you're an investor, it may be wise to consider public companies with the right resources to penetrate the medical market, especially if full legalization goes through.
The three companies in the marijuana industry whose future looks bright according to insiders are Innovative Industrial Properties (NYSE:IIPR), Trulieve Cannabis (CNSX:TRUL), and Village Farms International (NASDAQ:VFF).
>> Read More Cannabis Education
Featured Image: Pixabay © TerreDiCannabis
